Pre-analytical factors and measurement uncertainty.

Clinical laboratory measurements face challenges due to pre-analytical factors that introduce variation. These factors are now central to accreditation standards. Prior research has shown that biological and procedural variables affect test accuracy. However, no prior work had resolved how to estimate uncertainty from these diverse sources. This paper addresses that gap by combining experimental data with literature. It focuses on common chemical and haematological tests. The study does not introduce new techniques but provides a systematic approach. It aims to inform quality specifications for laboratory services. This approach is necessary to meet evolving accreditation requirements.

The study aimed to estimate measurement uncertainty for common clinical tests. It combined pre-analytical, analytical, and biological variation data. The goal was to support quality specifications for laboratory services. The researchers focused on serum cholesterol, albumin, potassium, and other analytes. They wanted to identify which factors contributed most to uncertainty. The study did not seek to develop new methods but to apply existing knowledge. It aimed to provide a framework for regional laboratory accreditation. This approach helps standardize quality across clinical settings.

The researchers used pragmatic experiments to estimate pre-analytical uncertainty components. They combined these with data on analytical variation and biological variation. The experiments focused on common chemical and haematological tests. The study used literature to supplement experimental data where needed. No new tools were developed for this purpose. The approach followed accreditation standards for uncertainty estimation. The researchers calculated expanded uncertainties at 95% confidence. The methods included statistical analysis of combined variation sources.

The expanded measurement uncertainty for serum cholesterol was 13-16%. Biological variation was the main contributor for cholesterol. Albumin and potassium had uncertainties of 13-16% as well. Sample collection and pretreatment were key for these analytes. Serum free thyroxin had a 20% uncertainty, mostly due to biological variation. Thyrotropin and C-reactive protein had higher uncertainties at 42% and 125%. Erythrocyte parameters had uncertainties below 10%. Thrombocyte and leukocyte counts had 24% and 31% uncertainties, respectively.

The study found that biological variation was a major source of uncertainty for several analytes. Sample collection and pretreatment also played significant roles in some cases. The expanded uncertainties varied widely across different tests. The findings help define quality specifications for laboratory services. The results align with accreditation standards for measurement uncertainty. The study did not propose new methods but applied existing knowledge. It highlights the need for systematic uncertainty estimation in clinical labs. These conclusions support improved quality assurance in laboratory diagnostics.